期刊
CANCER MANAGEMENT AND RESEARCH
卷 7, 期 -, 页码 253-264出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/CMAR.S58285
关键词
HIF-1; cancer; chemoresistance; signaling; apoptosis
类别
资金
- National Institutes of Health [RO1CA155413]
- NATIONAL CANCER INSTITUTE [R01CA155413] Funding Source: NIH RePORTER
Hypoxic tumors are associated with poor clinical outcome for multiple types of human cancer. This may be due, in part, to hypoxic cancer cells being resistant to anticancer therapy, including radiation therapy, chemotherapy, and targeted therapy. Hypoxia inducible factor 1, a major regulator of cellular response to hypoxia, regulates the expression of genes that are involved in multiple aspects of cancer biology, including cell survival, proliferation, metabolism, invasion, and angiogenesis. Here, we review multiple pathways regulated by hypoxia/hypoxia inducible factor 1 in cancer cells and discuss the latest advancements in overcoming hypoxia-mediated tumor resistance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据